Search
for
Sort by
Research 571–600 of 1000+
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Improving stable isotopic interpretations made from human hair through reduction of growth cycle error
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- PCOS in adolescents
- Causes of hair loss and the developments in hair rejuvenation
- Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators
- Dermatology of androgen-related disorders
- Finasteride Blocks the Reduction in Ictal Activity Produced by Exogenous Estrous Cyclicity
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- HRT for women with premature ovarian insufficiency: a comprehensive review
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Menopause and aging, quality of life and sexuality
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Increased Androgen Binding Capacity in Sebaceous Glands in Scalp of Male-pattern Baldness
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Idiopathic Hirsutism*
- Hormonal treatment of acne vulgaris: an update
- 5α-Reduced glucocorticoids: a story of natural selection
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands